Loading institutional data...
Loading institutional data...
Held by 289 of 5,944 reporting institutions (94th percentile) — extremely crowded.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
Ranked against 1085 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-03-31.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| BCAX | $1.24T | — | — | — | — | — | — | -34.4% | -34.4% | — | 143 |
| LLY | $1.03T | 50.2× | — | 15.9× | 44.7% | 83.0% | 31.7% | 77.8% | 29.9% | — | 4,193 |
| AKTX | $829.3B | — | — | — | — | — | — | -61.1% | -61.1% | — | 1 |
| JNJ | $650.0B | 24.5× | — | 6.9× | 6.0% | 67.9% | 28.5% | 32.9% | 20.7% | — | 4,451 |
| ABBV | $466.9B | 111.8× | 33.4× | 7.6× | 8.6% | 70.2% | 6.9% | -129% | 6.6% | 4.2× | 3,895 |
| MRK | $367.5B | 20.2× | — | 5.7× | 1.3% | 74.8% | 28.1% | 34.7% | 17.9% | — | 3,594 |
| UNH | $341.5B | 28.5× | 19.8× | 0.8× | 11.8% | 88.7% | 2.7% | 12.0% | 6.8% | 3.9× | 2,891 |
| AZN | $257.6B | — | — | — | — | — | — | — | — | — | 1,248 |
| TMO | $245.6B | 36.7× | 31.7× | 5.5× | 3.9% | — | 15.0% | 12.6% | 7.0% | 4.9× | 2,481 |
| AMGN | $207.8B | 27.1× | 17.8× | 5.7× | 10.0% | 67.2% | 21.0% | 89.1% | 12.2% | 3.8× | 3,014 |
| GILD | $186.3B | 22.1× | 20.3× | 6.3× | 2.4% | 78.8% | 28.9% | 37.5% | 17.9% | 2.4× | 2,218 |
| ABT | $178.6B | 27.6× | 19.3× | 4.0× | 5.7% | 56.4% | 14.7% | 12.5% | 10.0% | 1.4× | 2,964 |
| PFE | $157.2B | 20.3× | — | 2.5× | -1.6% | 74.3% | 12.4% | 9.0% | 5.1% | — | 2,838 |
| DHR | $149.7B | 41.9× | 30.9× | 6.1× | 2.9% | 59.1% | 14.7% | 6.9% | 5.1% | 3.4× | 2,083 |
| ISRG | $139.7B | 50.0× | 38.4× | 13.9× | 20.5% | 66.0% | 28.4% | 16.0% | 16.0% | — | 2,190 |
| VRTX | $129.1B | 33.2× | 28.3× | 10.8× | 8.9% | 86.2% | 32.9% | 21.2% | 21.2% | — | 1,609 |
| BMY | $128.3B | 18.2× | — | 2.7× | -0.2% | 71.1% | 14.6% | 38.2% | 11.1% | — | 2,431 |
| MDT | $117.9B | 24.7× | 12.5× | 3.2× | 8.4% | 65.0% | 13.2% | 9.7% | 9.4% | 0.2× | 2,114 |
| CVS | $112.9B | 63.9× | 11.3× | 0.3× | 7.8% | 45.0% | 0.4% | 2.4% | 2.4% | 0.0× | 1,795 |
| SYK | $105.2B | 32.8× | 18.1× | 4.2× | 11.2% | 64.0% | 12.9% | 14.5% | 8.5% | 2.5× | 2,196 |
| MCK | $102.0B | 22.8× | 16.1× | 0.3× | 12.4% | 3.6% | 1.2% | -219% | 109% | 1.0× | 1,946 |
| HCA | $96.1B | 15.1× | — | 1.3× | 7.1% | — | 9.0% | -113% | 16.8% | — | 1,346 |
| ELV | $90.7B | 16.3× | 15.4× | 0.5× | 12.5% | 89.4% | 2.8% | 12.9% | 7.6% | 4.2× | 1,397 |
| REGN | $82.1B | 18.9× | 19.6× | 5.7× | 1.0% | — | 31.4% | 14.4% | 13.6% | 0.5× | 1,336 |
| CI | $72.5B | 12.4× | 5.5× | 0.3× | 11.2% | 21.8% | 2.2% | 14.3% | 14.1% | 0.0× | 1,583 |
| FOLD | — | — | — | — | 20.0% | 88.5% | -4.3% | -9.9% | -4.1% | 9.8× | 289 |
Peers = companies sharing FOLD's sector (Healthcare) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
Safe > 2.99 · grey 1.81–2.99 · distress < 1.81 · book equity (no price)
Eight indices comparing this year to last (receivables, margins, asset quality, growth, accruals, leverage). Above −1.78 suggests possible manipulation; below −2.22 is clean.
A screen, not proof — high growth alone can raise it.
Cash-conversion data unavailable. Lower/negative accruals = higher quality (Sloan).
Interest coverage is thin — monitor; leverage falling year-over-year.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
No dividend to cover. Last year: $0 dividends + $0 buybacks = $0 returned on $30M FCF.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 10 years — and what it earned on reinvestment.
A reinvestment story — most cash went back into growth rather than to shareholders.
Reinvestment has been productive — operating income grew well per dollar put in. Current ROIC on all capital: -4%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Cash of $214M covers all $15M of scheduled principal — no refinancing pressure. Scheduled principal only (excludes interest & revolver draws). As of 2013-12-31 (10-K).
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Thin coverage — earnings barely cover interest. Effective rate ~11.8% on $393M of debt.
Cash vs short-term debt unavailable.
Mostly long-term debt (balance-sheet current vs non-current split). See the maturity ladder above for the year-by-year repayment schedule.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Maturity ladder from the SEC long-term-debt repayment schedule. Educational — not a recommendation.
No current price collected.
Where each multiple sits in its own 14-yr range
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 14-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
Watch the leverage lever — a chunk of ROE comes from the balance sheet.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
High operating leverage: profit moved 1.6× as fast as sales — great in an upturn, painful in a downturn.
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 15.8 | 12.1 | 11.9 | 11.3 | 11.7 | 9.3 | 10.0 | 11.5 |
| Gross Profit | 84.2 | 87.9 | 88.1 | 88.7 | 88.3 | 90.7 | 90.0 | 88.5 |
| SG&A | 139.4 | 93.2 | 60.0 | 63.1 | 64.7 | 68.9 | 61.2 | 60.5 |
| Operating Income | -360.3 | -166.8 | -94.7 | -67.6 | -64.4 | -19.3 | 4.7 | 5.2 |
| Income Tax | -0.1 | 0.3 | 1.0 | 2.9 | -1.7 | 0.4 | 5.2 | 4.3 |
| Net Income | -382.5 | -195.6 | -106.1 | -82.0 | -71.9 | -38.0 | -10.6 | -4.3 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on FOLD: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.
How a revenue dollar becomes profit — FY2025
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $634.2M 100.0% | $528.3M 100.0% | $399.4M 100.0% | $329.2M 100.0% | $305.5M 100.0% | $260.9M 100.0% | $182.2M 100.0% | $91.2M 100.0% | $36.9M 100.0% | $5.0M 100.0% |
| Cost of Revenue | $72.9M 11.5% | $52.9M 10.0% | $37.3M 9.3% | $38.6M 11.7% | $34.5M 11.3% | $31.0M 11.9% | $22.0M 12.1% | $14.4M 15.8% | $6.2M 16.9% | $833K 16.8% |
| Cost of Products | — | — | — | — | — | — | — | — | $6.2M 16.9% | $833K 16.8% |
| Gross Profit | $561.3M 88.5% | $475.4M 90.0% | $362.0M 90.7% | $290.6M 88.3% | $271.0M 88.7% | $229.8M 88.1% | $160.3M 87.9% | $76.8M 84.2% | $30.7M 83.1% | $4.1M 83.2% |
| Selling, General & Admin | $383.5M 60.5% | $323.4M 61.2% | $275.3M 68.9% | $213.0M 64.7% | $192.7M 63.1% | $156.4M 60.0% | $169.9M 93.2% | $127.2M 139.4% | $88.7M 240.1% | $71.2M 1435.1% |
| Total Operating Expenses | $528.5M 83.3% | $450.5M 85.3% | $439.2M 110.0% | $502.8M 152.7% | $477.5M 156.3% | $476.8M 182.8% | $464.3M 254.8% | $405.6M 444.5% | $472.7M 1279.9% | $186.0M 3751.8% |
| Operating Income | $32.8M 5.2% | $24.9M 4.7% | -$77.2M -19.3% | -$212.1M -64.4% | -$206.4M -67.6% | -$247.0M -94.7% | -$304.0M -166.8% | -$328.8M -360.3% | -$442.0M -1196.8% | -$181.9M -3668.6% |
| Interest Expense | $46.2M 7.3% | $49.6M 9.4% | $50.1M 12.6% | $37.1M 11.3% | $32.5M 10.6% | $22.4M 8.6% | $18.9M 10.4% | $22.4M 24.6% | $17.2M 46.7% | $5.4M 108.9% |
| Interest & Investment Income | $3.3M 0.5% | $5.4M 1.0% | $7.1M 1.8% | $3.0M 0.9% | $509K 0.2% | $3.2M 1.2% | $10.2M 5.6% | $10.5M 11.5% | $4.1M 11.1% | $1.6M 32.3% |
| Other Income (Expense), net | $10.2M 1.6% | -$9.4M -1.8% | -$15.9M -4.0% | $4.2M 1.3% | -$2.9M -0.9% | -$781K -0.3% | -$2.6M -1.4% | -$5.6M -6.2% | $6.0M 16.3% | -$4.8M -96.7% |
| Pretax Income | $191K 0.0% | -$28.8M -5.4% | -$150.1M -37.6% | -$242.0M -73.5% | -$241.6M -79.1% | -$274.3M -105.1% | -$355.9M -195.3% | -$349.1M -382.6% | -$449.1M -1216.1% | -$203.8M -4110.1% |
| Income Tax Expense | $27.3M 4.3% | $27.4M 5.2% | $1.5M 0.4% | -$5.5M -1.7% | $8.9M 2.9% | $2.6M 1.0% | $478K 0.3% | -$94K -0.1% | -$165.1M -447.1% | -$3.7M -75.4% |
| Net Income | -$27.1M -4.3% | -$56.1M -10.6% | -$151.6M -38.0% | -$236.6M -71.9% | -$250.5M -82.0% | -$276.9M -106.1% | -$356.4M -195.6% | -$349.0M -382.5% | -$284.0M -769.0% | -$200.0M -4034.7% |
| Per Share | ||||||||||
| EPS (Basic) | $-0.09 | $-0.18 | $-0.51 | $-0.82 | $-0.92 | $-1.07 | $-1.48 | — | — | — |
| EPS (Diluted) | $-0.09 | $-0.18 | $-0.51 | $-0.82 | $-0.92 | $-1.07 | $-1.48 | — | — | — |
| Weighted Avg Shares (Basic) | 308.4M | 304.4M | 295.2M | 289.1M | 271.4M | 258.9M | 240.4M | — | — | — |
| Weighted Avg Shares (Diluted) | 308.4M | 304.4M | 295.2M | 289.1M | 271.4M | 258.9M | 240.4M | — | — | — |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.